(Q36533049)

English

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease

scientific article published on November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

type 2 diabetes

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Robert J. Heine

6

object named as

Robert J Heine

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Jacqueline M Dekker

3

object named as

Jacqueline M Dekker

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Michaela Diamant

2

object named as

Michaela Diamant

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Roger K. Schindhelm

1

object named as

Roger K Schindhelm

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

5

object named as

Tom Teerlink

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

author name string

Maarten E Tushuizen

4

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

437-443

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Alanine aminotransferase levels: what's normal?

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

21 January 2018

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

21 January 2018

Evaluation of blood donors with elevated serum alanine aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

21 January 2018

Normal serum alanine aminotransferase activity in uncomplicated obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

21 January 2018

Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

21 January 2018

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic steatohepatitis: definition and pathology

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-alcoholic fatty liver: another feature of the metabolicsyndrome?

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of serum gamma-glutamyltransferase in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Is brain a gluconeogenic organ?

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability of serum alanine aminotransferase activity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term freezer storage, thawing, and refreezing on selected constituents of serum

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability of plasma analytes after delayed separation of whole blood: implications for epidemiological studies

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Diurnal variation of serum alanine transaminase activity in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete amino acid sequence of human liver cytosolic alanine aminotransferase (GPT) determined by a combination of conventional and mass spectral methods

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Human glutamate pyruvate transaminase (GPT): localization to 8q24.3, cDNA and genomic sequences, and polymorphic sites

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Noninvasive in vivo quantitative assessment of fat content in human liver

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and effectiveness of liver screening program to detect fatty liver in the periodic health check-ups

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

The elusiveness of "normal" ALT in fatty liver

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent alanine aminotransferase elevation in healthy Swedish blood donors--mainly caused by obesity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver function tests in diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of combining serum alanine aminotransferase levels and body mass index to predict mortality and medical costs: a 10-year follow-up study of National Health Insurance in Shiga, Japan

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis of steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Inverse association between serum adiponectin level and transaminase activities in Japanese male workers

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Dietary fat content modifies liver fat in overweight nondiabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Interorganal relationships of amino acid metabolism in fed rats

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.666

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.666

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36533049&oldid=1753543566"